←
Lior Shaltiel86 posts
Lior Shaltiel avatar

Lior Shaltiel

@liorshal
◷ Joined June 2009▧ 2 Photos and videos
Progress, Potential, And Possibilities avatar
⟳ Lior Shaltiel retweeted
Progress, Potential, And Possibilities@ProgressPotent1·Apr 7

What if paralysis 👨‍🦽 wasn’t permanent - or at least not untreatable? What if we could deliver regenerative signals to the central nervous system… through a simple intranasal spray? In our latest @ProgressPotent1, @liorshal (CEO of @NBiologic) breaks down the science behind ExoPTEN - an exosome-based therapy designed to deliver siRNA and temporarily silence the PTEN signaling pathway, one of the nervous system’s key “brakes” on regeneration. 🚀 In preclinical models, this approach has shown something rarely seen in this field: meaningful functional recovery after severe spinal cord injury. We explore: - Why the central nervous system struggles to regenerate; - Whether exosomes can finally solve the delivery problem; - Dr. Shaltiel’s journey-from ion channel biophysics to leading one of the more ambitious bets in neuroregeneration; Watch here: youtube.com/watch?v=AbSSUQ_E… #Biotech #Neuroscience #SpinalCordInjury #RegenerativeMedicine #Exosomes #Neuroregeneration #GeneSilencing #FutureOfMedicine #HealthTech #Longevity @russopartners @HebrewU

Post attachment
NurExone Biologic (TSXV: NRX) (Germany: J90) avatar
⟳ Lior Shaltiel retweeted
NurExone Biologic (TSXV: NRX) (Germany: J90)@NBiologic·9 Sep 2025

🔬✨ In biotech, IP is a great moat!! Proud that we received a U.S. Patent Allowance for our proprietary process of producing exosomes! globenewswire.com/news-relea…

NurExone Biologic (TSXV: NRX) (Germany: J90) avatar
⟳ Lior Shaltiel retweeted
NurExone Biologic (TSXV: NRX) (Germany: J90)@NBiologic·12 Aug 2025

The Science Behind the Magic ✨ Drug Discovery World took a deep look at the mechanisms behind our exosome therapy, designed to help damaged nerves regenerate, rewire and recover, and what it takes to translate to clinical . Read more: ddw-online.com/regenerate-re…

NurExone Biologic (TSXV: NRX) (Germany: J90) avatar
⟳ Lior Shaltiel retweeted
NurExone Biologic (TSXV: NRX) (Germany: J90)@NBiologic·24 Mar 2024

globenewswire.com/news-relea… Large scale preclinical testing to be performed on ExoPTEN.. A step closer to clinical trials and added hope for patients with acute spinal cord injuries.... #ExoTherapy #Nanodrugs #OrphanDrugs #Medicalinnovation

Eylon Levy avatar
⟳ Lior Shaltiel retweeted
Eylon Levy@EylonALevy·23 Nov 2023

The first question that left me speechless (but only for a second):

1:06
NurExone Biologic (TSXV: NRX) (Germany: J90) avatar
⟳ Lior Shaltiel retweeted
NurExone Biologic (TSXV: NRX) (Germany: J90)@NBiologic·8 Aug 2023

Compliments to our CEO Dr. Lior Shaltiel, PhD as per his recent nomination as co-chair of the Israeli organization for engineering, architecture and technological industries - the Med-Tech. finance.walla.co.il/item/359… #biotechnology #israelitech #engineering #biotechorganization

Lior Shaltiel avatar
Lior Shaltiel@liorshal·3 Jul 2023

I mark personally a significant milestone as NurExone Biologic celebrates its one-year anniversary as a public traded company! 🚀 🎉 I extend our heartfelt thanks to our incredible team, supportive shareholders, and valued stakeholders for their crucial…lnkd.in/dG5Qw-3e